[Form 4] UNITEDHEALTH GROUP INC Insider Trading Activity
Timothy P. Flynn, a director of UnitedHealth Group Inc. (UNH), received 272 deferred stock units on 10/01/2025 as regular quarterly director compensation at a reported price of $0. The filing shows 9,810 shares beneficially owned following the transaction and an additional 6,033 shares held indirectly by trust. The form explains these deferred stock units are immediately vested but must be retained until the director leaves the board. The Form 4 was signed by an attorney-in-fact and dated 10/03/2025.
Timothy P. Flynn, un amministratore di UnitedHealth Group Inc. (UNH), ha ricevuto 272 unità azionarie differite in data 10/01/2025 come compenso trimestrale normale per i direttori al prezzo riportato di $0. La pratica mostra 9.810 azioni detenute in modo beneficiario a seguito della transazione e ulteriori 6.033 azioni detenute indirettamente da trust. Il modulo spiega che queste unità azionarie differite sono immediatamente vestite ma devono essere conservate finché il direttore rimane nel consiglio. Il Modulo 4 è stato firmato da un procuratore-in-fatto e datato 10/03/2025.
Timothy P. Flynn, un director de UnitedHealth Group Inc. (UNH), recibió 272 unidades de acciones diferidas el 10/01/2025 como compensación trimestral regular para directores a un precio reportado de $0. El filing muestra 9,810 acciones poseídas de forma beneficiosa tras la transacción y además 6,033 acciones indirectamente por fideicomiso. El formulario explica que estas unidades de acciones diferidas se consolidan de inmediato pero deben conservarse hasta que el director deje la junta. El Formulario 4 fue firmado por un apoderado y fechado el 10/03/2025.
Timothy P. Flynn은 UnitedHealth Group Inc. (UNH)의 이사로서 10/01/2025에 272개의 지연 주식 유닛(deferred stock units)을 정기 분기 이사 보상으로 받았으며 보고된 가격은 $0이다. 제출문서는 거래 후 9,810주 이익 소유 주식이 있으며 6,033주가 신탁에 의해 간접 보유되고 있음을 보여준다. 양식은 이러한 지연 주식 유닛이 즉시 귀속되지만 이사가 이사회에서 물러날 때까지 보유해야 한다고 설명한다. Form 4은 대리인에 의해 서명되었고 10/03/2025로 날짜가 기재되어 있다.
Timothy P. Flynn, un directeur de UnitedHealth Group Inc. (UNH), a reçu 272 unités d’actions différées le 10/01/2025 comme compensation trimestrielle régulière des administrateurs à un prix déclaré de $0. Le dossier indique 9 810 actions détenues bénéficiairement à la suite de la transaction et 6 033 actions détenues indirectement par fiducie. Le formulaire explique que ces unités d’actions différées sont immédiatement acquises mais doivent être conservées tant que l’administrateur est sur le conseil. Le Formulaire 4 a été signé par un mandataire et daté du 10/03/2025.
Timothy P. Flynn, ein Direktor der UnitedHealth Group Inc. (UNH), erhielt am 10/01/2025 272 Deferred Stock Units als reguläre vierteljährliche Directorsvergütung zu einem gemeldeten Preis von $0. Die Anmeldung zeigt 9.810 Aktien, die nach der Transaktion wohlerwahrend gehalten werden, sowie zusätzlich 6.033 Aktien, die indirekt durch Treuhand gehalten werden. Das Formular erklärt, dass diese Deferred Stock Units sofort vesten, aber bis zum Verlassen des Direktorenstuhls gehalten werden müssen. Das Formblatt 4 wurde von einem Bevollmächtigten unterschrieben und auf 10/03/2025 datiert.
Timothy P. Flynn، مدير لدى UnitedHealth Group Inc. (UNH)، تلقّى 272 وحدة أسهم مؤجَّلة كتعويض دوري ربع سنوي للمدير عند سعر مُعلَن وهو $0 في 10/01/2025. تُظهر الإيداع 9,810 أسهم مملوكة فائدة بعد المعاملة و< b>6,033 أسهم أخرى مملوكة بصورة غير مباشر من خلال ثقة/وكالة ائتمانية. يشرح النموذج أن هذه الوحدات المؤجَّلة للأسهم مُحققة فورا لكنها يجب الاحتفاظ بها حتى يغادر المدير المجلس. تم توقيع النموذج Form 4 بواسطة وكيل قانوني وتاريخ 10/03/2025.
Timothy P. Flynn,UnitedHealth Group Inc.(UNH)的 董事,于 10/01/2025 收到 272 股权延期单位,作为常规季度董事酬金,披露价格为 $0。 文件显示在交易后有 9,810 股受益拥有股票,另有 6,033 股通过信托间接持有。 表格解释这些延期股票单位立即归属,但必须在董事离开董事会前保留。 Form 4 由代理人签署,日期为 10/03/2025。
- 272 deferred stock units granted as regular director compensation, reflecting continued alignment with shareholder interests
- Deferred stock units are immediately vested, giving the director ownership rights upon grant
- Retention requirement until board service completion promotes long-term alignment
- Form 4 discloses both direct (9,810) and indirect (6,033) holdings, providing transparency
- None.
Insights
Director received routine deferred stock units; retention until service end aligns with long-term alignment.
The filing documents a standard compensation practice: 272 deferred stock units granted as quarterly director pay and immediately vested but subject to mandatory retention until board service ends. This structure encourages retention of equity-based compensation without immediate sale.
The report lists 9,810 shares beneficially owned and 6,033 shares held indirectly by trust, clarifying the director's current equity stake as disclosed.
Grant is routine, non-cash director compensation; no purchase price and immediate vesting noted.
The transaction code and the $0 price indicate the units were awarded, not purchased. Immediate vesting means Flynn has ownership rights, while the retention requirement restricts disposition until departure from the board.
This is a regular quarterly award, so the transaction appears procedural rather than a material change in ownership percentage.
Timothy P. Flynn, un amministratore di UnitedHealth Group Inc. (UNH), ha ricevuto 272 unità azionarie differite in data 10/01/2025 come compenso trimestrale normale per i direttori al prezzo riportato di $0. La pratica mostra 9.810 azioni detenute in modo beneficiario a seguito della transazione e ulteriori 6.033 azioni detenute indirettamente da trust. Il modulo spiega che queste unità azionarie differite sono immediatamente vestite ma devono essere conservate finché il direttore rimane nel consiglio. Il Modulo 4 è stato firmato da un procuratore-in-fatto e datato 10/03/2025.
Timothy P. Flynn, un director de UnitedHealth Group Inc. (UNH), recibió 272 unidades de acciones diferidas el 10/01/2025 como compensación trimestral regular para directores a un precio reportado de $0. El filing muestra 9,810 acciones poseídas de forma beneficiosa tras la transacción y además 6,033 acciones indirectamente por fideicomiso. El formulario explica que estas unidades de acciones diferidas se consolidan de inmediato pero deben conservarse hasta que el director deje la junta. El Formulario 4 fue firmado por un apoderado y fechado el 10/03/2025.
Timothy P. Flynn은 UnitedHealth Group Inc. (UNH)의 이사로서 10/01/2025에 272개의 지연 주식 유닛(deferred stock units)을 정기 분기 이사 보상으로 받았으며 보고된 가격은 $0이다. 제출문서는 거래 후 9,810주 이익 소유 주식이 있으며 6,033주가 신탁에 의해 간접 보유되고 있음을 보여준다. 양식은 이러한 지연 주식 유닛이 즉시 귀속되지만 이사가 이사회에서 물러날 때까지 보유해야 한다고 설명한다. Form 4은 대리인에 의해 서명되었고 10/03/2025로 날짜가 기재되어 있다.
Timothy P. Flynn, un directeur de UnitedHealth Group Inc. (UNH), a reçu 272 unités d’actions différées le 10/01/2025 comme compensation trimestrielle régulière des administrateurs à un prix déclaré de $0. Le dossier indique 9 810 actions détenues bénéficiairement à la suite de la transaction et 6 033 actions détenues indirectement par fiducie. Le formulaire explique que ces unités d’actions différées sont immédiatement acquises mais doivent être conservées tant que l’administrateur est sur le conseil. Le Formulaire 4 a été signé par un mandataire et daté du 10/03/2025.
Timothy P. Flynn, ein Direktor der UnitedHealth Group Inc. (UNH), erhielt am 10/01/2025 272 Deferred Stock Units als reguläre vierteljährliche Directorsvergütung zu einem gemeldeten Preis von $0. Die Anmeldung zeigt 9.810 Aktien, die nach der Transaktion wohlerwahrend gehalten werden, sowie zusätzlich 6.033 Aktien, die indirekt durch Treuhand gehalten werden. Das Formular erklärt, dass diese Deferred Stock Units sofort vesten, aber bis zum Verlassen des Direktorenstuhls gehalten werden müssen. Das Formblatt 4 wurde von einem Bevollmächtigten unterschrieben und auf 10/03/2025 datiert.